KALIG-1 Polyclonal Antibody

Mutations in KAL1 cause the X-linked Kallmann syndrome. Anosmin-1 is similar in sequence to proteins known to function in neural cell adhesion and axonal migration. In addition, this cell surface protein is N-glycosylated and may have anti-protease activity.

Introducing the KALIG-1 Polyclonal Antibody, a cutting-edge immunological tool designed to facilitate accurate and efficient detection of KALIG-1 protein expression. This meticulously developed antibody is meticulously crafted using state-of-the-art techniques, ensuring exceptional specificity and sensitivity for a wide range of applications in various research fields.

The KALIG-1 Polyclonal Antibody boasts an impressive affinity for the KALIG-1 protein, enabling precise identification and quantification of its expression levels. This antibody has been rigorously validated through extensive testing, guaranteeing reliable and reproducible results.

With its exceptional performance, the KALIG-1 Polyclonal Antibody is an invaluable asset for researchers seeking to unravel the intricate mechanisms underlying KALIG-1 protein function. Its versatility allows for utilization in diverse experimental techniques, including Western blotting, immunohistochemistry, and immunofluorescence.

Furthermore, the KALIG-1 Polyclonal Antibody is manufactured in strict compliance with the highest quality standards, ensuring batch-to-batch consistency and reliability. Its formulation is optimized to minimize non-specific binding, thereby enhancing signal-to-noise ratios and enabling accurate interpretation of experimental data.

In summary, the KALIG-1 Polyclonal Antibody represents a breakthrough in immunological research, offering unparalleled specificity, sensitivity, and versatility. With its exceptional performance and stringent quality control measures, this antibody is poised to revolutionize the study of KALIG-1 protein expression and function.